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1. Introduction 
Low-Density Lipoprotein (LDL) is the major carrier of cholesterol in the blood and plays 
important physiological roles in cellular function and regulation of metabolic pathways. 
Nevertheless, there are unquestionable evidences that increased plasma levels of LDL, 
especially their modified particles, are associated with atherosclerosis (Miller et al., 2010; 
Levitan et al., 2010). Atherosclerosis is a chronic disease that develops progressively through 
the continuous evolution of arterial wall lesions centered on the accumulation of cholesterol-
rich lipids, several types of cells and an accompanying immune-inflammatory response 
(Libby et al., 2009). This disease begins in childhood, progresses relatively silently during 
adolescence and early adulthood but becomes clinically evident in the middle age or later 
leading to events such as myocardial infarction and stroke (McGill et al., 2000). The 
atherosclerotic cardiovascular disease is a major health problem worldwide and the most 
common cause of death in westernized countries, leading to a substantial economic burden. 
Whereas the levels of LDL and modified LDL circulating forms in the plasma are important 
predictive markers to gauge risk of cardiovascular events, there is need to develop reliable 
rapid assays for quantifying LDL and its modified forms, such as, the biosensors. 
In general, biosensor is a measuring system that is composed by two major parts: a 
recognition part and a transducer part. The recognition part involves biological sensing 
elements or receptor molecules that lend the sensor specific to a target analyte (Chunta et al., 
2009; Cooper & Cass, 2004; Fowler et al., 2008). A variety of biological substances can be 
used including antibodies, affinity ligands, isolated receptors, enzymes, organelles, 
microorganisms, cells, tissues, oligonucleotides, and lipoproteins. When biological 
substances interact with the target analytes, there is a change in one or more 
physicochemical parameters such as generation of ions, gases, electrons, second messenger 
formation, increase or decrease in enzyme activity, heat or mass. The transducer can be used 
to convert these properties into electrical signal. 
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There are three main types of transducers applied to LDL detection: piezoelectric (mass 
sensitive), optical and electrochemical. Among all types of transducers, the piezoelectric 
device has been used like LDL sensor. Piezoelectric device, often named quartz crystal 
microbalance (QCM), shows a very high sensitivity for detecting the target analyte that is 
placed on the surface of the device and generates the resonant frequency change. A 
piezoelectric biosensor device has important attractive properties such as small size, 
rapidity with high throughput, high sensitivity, and specificity. Lipoprotein immunosensors 
based on piezoelectric technology have been applied to capture and detect ligands on 
lipoprotein particles (Snellings et al., 2003). At the same time to explore monoclonal LDL 
antibodies (MAbs) in the interaction with the main protein constituent of human low 
density lipoprotein (apoB-100) a surface plasmon resonance (SPR)-based biosensor has been 
employed. Using this technique it is possible to measure the multimolecular complex 
between MAbs and epitopes of the apoB-100 in real time (Matharu et al., 2009a). The SPR 
detects and measures changes in refractive index due to the binding and dissociation of 
interacting molecules at or in proximity to the gold surface. This change of the refractive 
index is proportional to the concentration of the interacting molecule and causes a shift in 
the angle of incidence at which the SPR phenomenon occurs.  
Electrochemical methods associated with nanomaterials have been employed to develop 
electrochemical biosensors for the detection of LDL. Cyclic voltammetry (CV) can be used to 
monitor the biomolecular interaction and explore association between antibody and LDL 
based on the modification at anodic and cathodic peaks (Stura et al., 2007). CV is an 
analytical technique to study the electro-activity of compounds, to characterize the redox 
properties and to provide information about the kinetics of electron transfer reaction of any 
coupled chemical reaction. Therefore, the advantage of electrochemical impedance 
spectroscopy (EIS) over other electrochemical techniques is that only small-amplitude 
perturbations from steady state are needed, and information concerning the interface can be 
provided (Bockris et al., 2000; Bard & Faulkner, 2001; Macdonald, 1987). In general, this 
system has been utilized to fabricate label-free high-sensitivity immunosensors with highly 
sensitive response to LDL (Yan et al., 2008). Hence, further studies based on LDL biosensors 
have been directed to diminish the detection time and develop new ways of detecting LDL 
and modified LDL. 
2. LDL and its modified forms 
The major lipids present in the blood plasma are cholesterol, fatty acids, triglycerides and 
phospholipids. Cholesterol is present in dietary fat, and can be synthesized in the liver by a 
mechanism that is under close metabolic regulation. Cholesterol, like all lipids, is not water 
soluble and thus, it is transported in the plasma in association with proteins 
(apolipoproteins), forming complexes known as lipoproteins. Lipoproteins are classified on 
the basis of their densities, which increases from chylomicrons through lipoproteins of very 
low density (VLDL), intermediate density (IDL) and low density (LDL) to high density 
lipoproteins (HDL) (Marshall & Bangert, 2008). The physiological function of LDL particles 
is to provide cells with the cholesterol they need mainly for steroid hormone synthesis and 
membrane formation. LDL particles assume a globular shape with an average diameter of 
about 22 nm and they are organized into two major compartments. An apolar core 
comprised primarily of cholesteryl esters, minor amounts of triglycerides and some free 
unesterified cholesterol surrounded by an amphipathic shell. This outer shell is composed of 
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a phospholipid monolayer containing most of the free unesterified cholesterol and one 
single molecule of apolipoprotein B-100 (apoB-100) (Prassl & Laggner, 2009). However, LDL 
particles can undergo in vivo modification by oxidation, glycation, nitration and 
carbamylation, among other reactions. The extent of LDL modification can range from 
minimal modification, resulting minimally modified particles, such as the electronegative 
LDL subfraction (Damasceno et al., 2006), to extensive oxidation. Oxidized LDL is a generic 
term that describes a variety of modifications of both the lipid and protein components of 
LDL. Transition metal ions, lipoxygenases, myeloperoxidase, peroxynitrite and other 
reactive nitrogen and oxygen species derived from this enzyme, among others, have been 
suggested to be responsible for in vivo oxidative modification of LDL in humans (Stocker & 
Keaney, 2004; Malle, et al., 2006). Reactive oxygen species induce fragmentation of apoB-100. 
The polyunsaturated fatty acids in cholesteryl esters, phospholipids and triglycerides are 
also subjected to free radical-initiated oxidation to yield a broad array of smaller fragments 
(Matsuura et al., 2008). This results in a variety of reactive aldehyde products, including (E)-
4-hydroxynon-2-enal (HNE) and malondialdehyde (MDA), which form covalent adducts 
with amino acid residues of LDL, generating HNE-LDL and MDA-LDL, respectively 
(Annangudi et al., 2008; Viigimaa et al., 2010). Glycated LDL is formed by the nonenzymatic 
covalent binding of reactive aldehydes (from glucose or related species) to a reactive amine 
(e.g., lysine and arginine side chains) on apoB-100 (Brown et al., 2007). The initial Schiff base 
undergoes subsequent rearrangement into Amadori products. The Amadori sugar–amino 
acid adducts can undergo progressive nonenzymatic reactions, leading to the formation of 
advanced glycation end (AGE) products, resulting in AGE-LDL (Basta et al., 2004; 
Hodgkinson et al., 2008). LDL can even be modified by urea-derived cyanate. Patients with 
kidney disease have elevated plasmatic levels of urea. Urea undergoes a spontaneous 
nonenzymatic transformation to cyanate in aqueous solutions and cyanate can react 
irreversibly with N-terminal groups of amino acids from LDL by a process known as 
carbamylation, forming carbamylated LDL (Asci et al., 2008). 
The modified LDL forms, independent of the type of modification, triggers various 
biological responses, including pro-inflammatory reactions potentially involved in 
atherogenesis, promoting endothelial cell injury, expression of adhesion molecules on 
endothelium and vascular smooth muscle cell proliferation. Moreover, the modified LDL is 
uptaken by macrophages via scavenger receptors resulting in the accumulation of 
cholesterol within the macrophages and the formation of foam cells in the arterial intima. 
This continuous process lead to advanced lesions in arteries with a core of lipids and 
necrotic tissue covered by a fibrous cap. Disruption of the cap can lead to thrombosis and 
many of the adverse clinical outcomes associated with atherosclerosis (Hansson & Libby, 
2006). As the LDL modified forms are proinflammatory and proatherogenic, studies have 
been done to develop a method to quantify the modified LDL subfraction as a blood 
biomarker to diagnose cardiovascular diseases and perhaps predict clinical outcomes. 
Plasma biomarkers have the advantage of being non-invasive and, if abnormal, allow 
opportunities of early stage intervention. 
3. Methods for measurement of LDL and modified LDL 
A classic method for measurement of LDL is the beta-quantification, which involves 
ultracentrifugation and a chemical precipitation step (Bachorik, 1997). Because beta-
quantification is cumbersome and requires sophisticated equipment, in most clinical 
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laboratories LDL is usually estimated by Friedewald equation (Friedewald et al., 1972), an 
indirect method, which estimates the LDL from measurements of total cholesterol (TC), 
triglycerides (TG), and HDL (Eq. 1). 
 ( / ) / 5LDL mg dL TC HDL TG    (1) 
Despite the simplicity and lack of cost, the error of determining LDL through that estimation 
comprises the addition of the analytical errors of the three parameters used in the calculus. 
In addition, the use of that formula has severe limitations and cannot be applied to samples 
containing TG levels > 400 mg/dL or in samples with chylomicrons, as occurs in non-fasting 
samples. Because of the limitations of the Friedewald calculation, some clinical laboratories 
use enzymatic colorimetric methods for quantification of LDL, which are direct, relatively 
simple, can be used in automated systems (Cordova et al., 2004; Esteban-Salan et al., 2008) 
and LDL values are not affected by the presence of increased levels of triglycerides (Rifai et 
al., 1998). The aforementioned methods quantify the total LDL (modified and unmodified 
fractions). In the last two decades, aiming to determine the modified LDL subfraction in the 
blood circulation, ELISAs (Enzyme-Linked Immunosorbent Assay) using monoclonal 
antibodies were developed. There are ELISAs used in research to measure oxidized LDL 
(Itabe & Ueda, 2007) and electronegative LDL (Faulin et al., 2008). ELISA is a method that 
has high sensitivity and specificity, low cost, technical simplicity, versatility and ability to 
adapt to different degrees of automation, however, it is a time-consuming test consisting of 
several steps. 
4. Biosensors 
A biosensor is a physicochemical analytical device for the detection of an interaction of the 
analyte that combines with a biological component, which recognizes a chemical or physical 
change, with a detector component that produces a measurable signal in response to the 
environmental change (Chunta et al., 2009; Cooper & Cass, 2004; Fowler et al., 2008). The 
characteristic trait of a biosensor is the direct spatial contact between the biological 
recognition element (or bioreceptor) and the transducing element (Thevenot et al., 1999). 
Therefore, biosensor is a measurement device or system that is composed of two major 
parts: a recognition part and a transducer part (Fig. 1).  
A biosensor is an integrated receptor-transducer device, which is capable of providing 
selective quantitative or semi-quantitative analytical information (Jambunathan & Hillier, 
2003). The biosensor consists, on the one hand, of a biological recognition element, which 
acts upon a biochemical mechanism, and of a transducer relying on electrochemical, mass, 
optical or thermal principles. 
Typical bioreceptors in biosensors are enzymes, antibodies, lectins, microorganisms and 
nucleic acids. In addition, the use of biosensors offer several benefits over conventional 
diagnostic tools as simplicity, specificity, speed, low-cost, portable instrumentation and 
capability for continuous monitoring in real-time (Freire et al., 2002; Malhotra et al., 2006; 
Zhao & Ju, 2006). LDL sensors (lipoprotein sensors) are a new promising group or 
bioreceptors, because of their outstanding selectivity and stability in responses that provides 
an evaluation about biomedical diagnosis in plasma LDL levels (Matharu et al., 2009a, 
2009b, 2010). New methods for diagnosis of LDL employing biosensors are the current 
demand to evaluate the risk factors for atherosclerosis. Thus, the basic principles of the 
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quartz crystal microbalance (QCM), surface plasmon resonance (SPR), cyclic voltammetry 
(CV) and electrochemical impedance spectroscopy (EIS) are discussed with the purpose of 
showing their importance in quantitative or qualitative LDL analysis. 
 
 
Fig. 1. Schematic diagram of a biosensor. A biosensor consists of a bioreceptor for the 
specific detection of the respective analyte in spatial contact to a transducer for converting 
the signal into an electrically manageable format and a signal processing unit. 
5. Quartz crystal microbalance 
Among biosensor devices, piezoelectric has been highly recognized due to their small size, 
low cost, use of a small volume of sample, high sensitivity, high specificity, rapid response, 
reproducibility and ease of portable multiple specific sensor array fabrication (Chunta et al., 
2009). The QCM is an ultra-sensitive weighing device (to measure or detect a small mass 
change) that utilizes the mechanical resonance of piezoelectric single-crystalline quartz 
(Höök & Rudh, 2005). The piezoelectricity was discovered by Jacques and Pierre Curie in 
1880 (Curie J. & Curie P., 1880a,b) as a potential difference generated across two surfaces of 
a crystal (including quartz, Rochelle salt and tourmaline) under strain, whose magnitude of 
electrical potential was proportional to the applied stress (Chunta et al., 2009; Höök & Rudh, 
2005; Smith, 2008). Therefore, piezoelectricity is defined as electric polarization produced by 
mechanical strain in certain crystals, the polarization being proportional to the strain (Smith, 
2008). 
Quartz crystals (Fig. 2a) are generally used as weighing devices. Quartz crystal can be cut in 
different angles which gives different quartz crystal types with specific properties. Typically 
for piezoelectric analytical work, quartz crystals are cut in the AT form, at a +35°15’ angle 
from the Z-axis (Bunde et al., 1998). This geometry has a zero temperature coefficient which 
provides a stable oscillation with almost no temperature fluctuation in frequency in wide 
temperature range (Höök & Rudh, 2005). In addition, quartz is the most commonly crystal 
used, due to its strong piezoelectric response, abundance, processability, and anisotropy. 
QCM is an important technique that has unique advantages for addressing the problems 
and issues involved in developing these new measurement methodologies (Marx, 2003). The 
use of the crystal resonator has been extended to numerous applications in different fields 
like electrochemistry and biology (Arnau, 2008). According to Smith (2008) the resonance 
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frequency depends upon the angles with respect to the optical axis at which the wafer was 
cut from a single crystal and inversely on the crystal thickness. 
 
 
 
Fig. 2. Experimental apparatus for a piezoelectric system (a) and piezoelectric effect for 
shear motion (b). 
5.1 Principles of mass measurement 
When an alternating-current (AC) voltage is applied across of AT-cut quartz crystal (Fig. 
2b), through opposing electrodes deposited on its surfaces, the resonance is excited if the 
frequency of the applied voltage corresponds to the resonance frequency (f0) of the crystal 
(Arnau, 2008; Chunta et al., 2009; Höök & Rudh, 2005; Smith, 2008). It generates a 
transversal acoustic wave propagating through the quartz to the contacting media and this 
condition occurs when the thickness of the disc is an odd integer number of half-
wavelengths of the standing wave induced between the electrodes, causing the mechanical 
oscillation to have its anti-nodes at each electrode interface (Höök & Rudh, 2005). The 
resonance frequency of the crystal is thus directly proportional to the total mass of the 
crystal. The frequency range for the fundamental mode of quartz is between 5 and 20 MHz 
(Marx, 2003). Although, most applications have used QCM devices operating in the 5-10 
MHz range. 
A method for correlating changes in the oscillation frequency of a piezoelectric crystal with 
the mass deposited on it was developed by Günter Sauerbrey (Sauerbrey, 1959). Sauerbrey 
developed a method for measuring the frequency and its changes by using the crystal as the 
frequency determining component of an oscillator circuit. The Sauerbrey equation is defined 
as: 
 
2
02
q q
mf
f C m
A  
       (2) 
where Δf is the change in the fundamental frequency (Hz), Δm is mass change (g), f0 is the 
resonant frequency of crystal (Hz), A is piezoelectrically active crystal area (area between 
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electrodes in cm2), ρq is density of quartz crystal (ρq = 2.648 g/cm3), μq is shear modulus of 
quartz for AT-cut crystal (μq = 2.947x1011 g/cm.s2), and C is the mass sensitivity constant 
(based on type of crystal used) (s.g-1). 
According to Bunde and collaborators (1998), Sauerbrey’s equation is based on the 
deposition of rigid layers that are infinitesimally thin and, thus, dampen the propagation of 
the bulk shear wave in a fashion identical to quartz itself. Since the film is treated as an 
extension of thickness, this approach only applies to systems in which the some conditions 
are present, as follow: deposited mass must be rigid, uniformly distributed and frequency 
change Δf/f < 0.02 (Srivastava & Sakthivel, 2001).  
This approach was developed for oscillation in air and only applies to rigid masses attached 
to the crystal. In the beginning of 80’s, scientists have been shown that quartz crystal 
microbalance measurements can be performed in Newtonian liquid. Kanazawa and 
collaborators (1985) showed that the change in the resonant frequency of quartz crystal that 
contacted with the liquid is expressed by: 
 3/2 1/20 ( )
L L
q q
f f
 
     (3) 
where L is the density of liquid in contact with the crystal and L is the viscosity of liquid in 
contact with the crystal (Kanazawa & Gordon II, 1985). 
5.2 Piezoelectric LDL biosensors 
Lipoprotein biosensors based on piezoelectric technology have been employed to capture 
and detect ligands on lipoprotein particles. The critical step in LDL detection is the selective 
separation of LDL from the other lipoprotein fractions (Snellings et al., 2003). A specific 
ligand for the LDL receptor is apoB-100 (Schumaker et al., 1994), a major apolipoprotein of 
LDL and a very large glycoprotein consisting of a single polypeptide chain of 4536 amino 
acid residues with a molar mass of 514 kDa (Yang et al., 1986). The entrapment of LDL in the 
arterial intima is mainly due to the specific interaction between the lysine-rich sites on apoB-
100 and the extracellular matrix (ECM) components such as collagen, proteoglycans (PGs), 
and glycosaminoglycans (GAGs) (D’Ulivo et al., 2010). Valuable techniques already exist for 
studies on apoB-100 and ECM interactions (D’Ulivo et al., 2009, 2010). In addition, other 
techniques as affinity chromatography and capillary electrochromatography are available 
for apoB–ECM interaction studies (D’Ulivo et al., 2009), but new microsystems and 
miniaturized instrumental tools are desirable to provide complementary information. 
D’Ulivo and collaborators (2010) explored the applicability of the QCM for interaction 
studies between apoB-100 peptide fragments and various components of the ECM. They 
selected three peptide residues from the apoB-100 sequence that are responsible for the 
binding of LDL with PGs (Skålén et al., 2002). One of these is a water-soluble peptide 
residue with 19 amino acids, positively charged (net charge of +6) that interacts selectively 
with the LDL receptor (Camejo et al., 1998). The second positive peptide, consisting of 42 
amino acids, has a net charge of +3. This peptide is fairly hydrophobic and soluble only in 
pure dimethyl sulfoxide and in lipids. Neutral peptide fragment with 11 amino acids was 
selected as control fragment, since it should not interact with the ECM components (D’Ulivo 
et al., 2009). Functionalized carboxyl and polystyrene sensor chips were used in this study to 
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evaluate the interactions between apoB-100 peptide fragments and components of the ECM. 
D’Ulivo and collaborators (2010) showed that apoB-100 peptides interact with ECM 
components via electrostatic interactions, most likely involving their positive residues, 
lysine and arginine, and that the binding is selective for GAGs. 
Others reports describe the use of QCM for on-line monitoring of the adsorption of LDL 
onto cholesterol-modified dextran (CMD) (Liu et al., 2007). Because LDL particles are the 
main carries of cholesterol transfer and metabolism, accumulation of LDL is regarded as the 
first stage of atherosclerotic lesions. These researchers have been engaged in evaluatin the 
hydrophobic adsorbent, CMD, to investigate the kinetic adsorption curves. Experimental 
results showed that this system was capable to predict the adsorption capacities and 
concentrations at ng/l. Many researchers have been involved in development of different 
kinds of adsorbents including non-specific, selective adsorbents and immuno-adsorbent 
according to the molecular structure of LDL (Behm et al., 1989; Bosch et al., 1997). 
Piezoelectric technique can be associated to SPR technique to obtain new immunosensor 
devices. Immunosensors are affinity ligand-based biosensing devices that involve the 
coupling of immunochemical reactions to appropriate transducers. In recent decades, 
immunosensors have received rapid development and wide applications with various 
detection formats (Luppa et al., 2001; Stefan et al., 2000). The general working principle of 
the immunosensors is based on the fact that the specific immunochemical recognition of 
antibodies (antigens) immobilized on a transducer to antigens (antibodies) in the sample 
media can produce analytical signals dynamically varying with the concentrations of 
analytes of interest. Matharu et al. (2009a) obtained an accurate and specific human plasma 
LDL immunosensor based on SPR and QCM by immobilizing anti-apolipoprotein B 
(AapoB) onto self-assembled monolayer of 4-aminothiophenol (AT). The AapoB/AT/Au 
immunosensor detected LDL up to 0.252 μM (84 mg/dl) and 0.360 μM (120 mg/dl) with 
sensitivity of 475.39 Hz/μM and 977.96 m°/μM by QCM and SPR techniques, respectively. 
The analysis of the values of association constants at different temperatures and the 
enthalpy of adsorption (ΔHads) indicated the AapoB-LDL interaction to be endothermic in 
nature. The positive value of entropy (TΔSads) was found to be greater than ΔHads indicating 
the adsorption process to be entropy driven. Kinetic, thermodynamic, and sticking 
probability studies revealed that desorption of water from LDL and AapoB surfaces play the 
most important role in the binding of LDL to AapoB which enhances with increase in the 
temperature. In addition, a label-free and reusable AapoB/AT/Au immunosensor was 
fabricated for estimation of LDL. 
6. Surface plasmon resonance 
Due to the introduction of sensitive bench top instruments and the expansion in the range of 
strategies for studying biological or biochemical systems (Green et al., 2000; Oliveira et al., 
2011) in more recent times, SPR based techniques have found expanded use and recently 
they have been introduced in clinical studies (Matharu et al., 2009a, 2009b). The competitive 
advantages of such techniques include the fact that SPR can be applied to a wide range of 
biomedically relevant interfaces and allows both real-time qualitative and quantitative 
assessments of the prevailing biomolecular interactions while eliminating the need of 
labeling reagents and without any complex sample preparation. The use of SPR technique to 
probe ligand-ligate surface interactions is advantageous, since it is able to rapidly monitor 
dynamic process, such as adsorption or degradation. SPR provides further information on 
www.intechopen.com
 
Biosensors for Detection of Low-Density Lipoprotein and its Modified Forms   
 
223 
the rate and extent of adsorption, enabling the determination of dielectric properties, 
association/dissociation kinetics and affinity constants of specific ligand-ligate interactions 
(Green et al., 2000). In addition, the SPR signal is highly sensitive to even small changes in 
the refractive index at the interface with a thin noble metal film (Helali et al., 2008). The 
phenomenon of anomalous diffraction on diffraction gratings due to the excitation of 
surface plasma waves was first described by Wood (1902). Otto (1968) and Kretschmann & 
Raether (1968) demonstrated the method of attenuated total reflection (ATR) for optical 
excitation of surface plasmons (SP). In the Otto setup, the light is shone on the wall of a 
prism and totally reflected. In this system a thin metal layer is positioned close enough, that 
the evanescent waves can interact with the plasma waves on the surface and excite the 
plasmons. In the case of Kretschmann configuration – widely used within the designs of 
most SPR instruments – relies on the phenomenon of ATR (Fig. 3). This phenomenon occurs 
when light travelling through an optically dense medium (e.g. glass) reaches an interface 
between this medium and a medium of a lower optical density (e.g. air), and is reflected 
back into the dense medium, and an evanescent wave penetrates through the noble metal 
layer (Green et al., 2000). The plasmons are excited at the outer side of the film. 
6.1 Theoretical background 
SPR is a quantum electromagnetic phenomenon arising from the interaction of light with 
free electrons at metal-dielectric interface, i.e., a charge-density oscillation propagating wave 
along the interface of two media with dielectric constants of opposite signs (Abdulhalim et 
al., 2008; Green et al., 2000; Homola et al., 1999; Lundstrom, 1994). A gold film in contact 
with a water interface is the most common system used in SPR experiments, since gold has a 
negative dielectric function () in the infrared and visible regions of the electromagnetic 
spectrum, whereas water has a positive dielectric function (Johnson & Christy, 1972). The 
energy carried by photons of light is transferred to collective excitations of free electrons, 
called SP, at that interface and this transfer of energy occurs only at a specific resonance 
wavelength of light when the momentums of the photon and the plasmon are matched 
(Abdulhalim et al., 2008). This condition is only satisfied at distinct angles of incidence, 
appearing as a drop in the reflectivity of incident light (Daghestani & Day, 2010; Novotny & 
Hecht, 2006). The field vectors of electromagnetic wave reach a maximum at the interface 
and decay evanescently with distance normal into a metal (typically gold or silver) and 
dielectric media. The SP propagates as an electromagnetic surface wave, which is a 
transverse magnetic-polarized wave (TM-PW). TM-PW can be defined as a magnetic vector 
perpendicular to the direction of propagation of the ESW and parallel to the plane of 
interface. Correlating the relationship between the wave vector along the interface and the 
angular frequency , the surface plasmons can have a range of energies that depends on the 
complex dielectric function of the metal (m) and the dielectric function of the adjacent 
medium (d), as shown by the following equation: 
 m dsp
m d
k
c
 
    (4) 
where ksp is the wave vector of the SP,  is the angular frequency, c is the speed of light in a 
vacuum, and m and d are the permittivity of a metal and a dielectric material, respectively 
(Raether, 1988). In the Eq. 4, the real part determines the SP wavelength and the imaginary 
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part determines the propagation length of the SP along the interface, which is responsible 
for the evanescent field (Daghestani & Day, 2010). 
According to Smith & Corn (2003) SP can be directly excited by electrons; however, they 
cannot be excited directly by light because they have a longer wave vector than light waves 
of the same energy (klight = /c). The wave vector of a photon must be increased to convert 
the photon into SP. A monochromatic p-polarized light source is used in SPR measurements 
and the interface between the two optically dense media is coated with a thin metal film 
(Fig. 3). The Eq. 4 under conditions of ATR (Kretschmann configuration) becomes, 
 sinATR pk
c
    (5) 
where p is the dielectric constant of the prism, and  is the angle of incidence of the light on 
the metal film (Raether, 1988). 
 
 
Fig. 3. Schematic diagram of SPR Kretschmann configuration. SPR1 and SPR2 represents 
the relation of SPR angle in the absence and presence of species on the metallic surface, 
respectively. 
When the parallel component of the incident light is equivalent to the SP propagation 
constant, i.e., kSP = kATR (Eq. 4 and 5) a drop in reflectance will be found, due to the 
formation of an evanescent wave, that propagates through the metallic surface and interacts 
with the external medium (Damos et al., 2004), as follow: 
 sinm d p
m dc c
      
 (6) 
which can be rewritten as 
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1
arcsin( ( ))m d
m d p
x
       (7) 
In this last expression it can be seen that the system optical properties, like the metal, prism 
and matrix dielectric constants, induce changes in the resonance angle, making it possible to 
apply the SPR phenomenon to monitor changes in the sensor surface (Damos et al., 2004). 
SPR technique relies on the principle that any changes on the dielectric sensing surface will 
cause a shift in the angle of reflectivity, followed by a detector, in order to satisfy the 
resonance condition (Daghestani & Day, 2010). 
6.2 SPR measurement 
In a simple SPR measurement, a target component or analyte is captured by the capturing 
element or so-called ligand and this ligand is permanently immobilized on the sensor 
surface previous to the measurement. The direct detection is the event of capturing the 
analyte by the ligand gives rise to a measurable signal. For each measurement, the surface is 
primed with a suitable buffer solution to create a baseline on the SPR curve (Green et al., 
2000). It is of vital relevance to have a reliable baseline before the capturing event starts 
(Tudos & Schasfoort, 2008). Once the biomolecule comes into contact with the surface, rapid 
adsorption occurs resulting in an increase in the SPR angle and is followed by a plateau in 
the adsorption profile due to saturation of the surface (Fig. 3a). Finally, the biomolecule 
solution is replaced with a buffer to remove loosely bound material. The difference between 
the SPR1 to SPR2 gives an indication on the extent of adsorption (Fig. 3b), and the positive 
gradient of the SPR adsorption curve determines the rate of adsorption (Damos et al., 2004; 
Green et al., 2000; Tudos & Schasfoort, 2008). 
 
 
 
 
Fig. 3. Sensorgram showing the steps of an analysis cycle of association and dissociation 
steps (a). A change in refractive index at the surface of the metal film will cause an angle 
shift from SPR1 to SPR2 (b). 
Often SPR measurements are carried out to determine the kinetics of a binding process. For 
realistic results it is vital to prevent immobilization from changing the ligand in a way that 
would influence its strength or affinity towards the target component (Tudos & Schasfoort, 
2008). 
www.intechopen.com
  
Biosensors for Health, Environment and Biosecurity 
 
226 
6.3 Optical LDL biosensor 
The SPR detects and measures changes in refractive index due to the binding and 
dissociation of interacting molecules at or in proximity to the gold surface. This change of 
the refractive index is proportional to the concentration of the interacting molecule and 
causes a shift in the angle of incidence at which the SPR phenomenon occurs. In addition, to 
explore monoclonal LDL antibodies in the interaction with the main protein constituent of 
human LDL (apoB-100) is possible to use a SPR-based biosensor to measure the 
multimolecular complex between MAbs and epitopes of the apoB-100 in real time. 
Robbio and collaborators (2001) using a SPR-based biosensor, studied the interaction of ten 
different murine MAbs (all IgG1), raised against apoB-100. These MAbs identify distinct 
domains on apoB-100, relevant to LDL-receptor interaction: epitopes in the amino-terminal 
region and in the middle region of native apoB-100. A multisite binding analysis was 
performed to further characterize the epitopes recognized by all these MAbs. The capacity 
of each MAb to interact with the entrapped apoB-100 in a multimolecular complex was 
monitored in real time by SPR. The results achieved were comparable to those obtained by 
western immunoblotting using the same reagents. However, SPR ensures a more detailed 
epitope identification, demonstrating that SPR technology can be successfully used for 
mapping distinct epitopes on apoB-100 protein in solution dispensing with labels and 
secondary tracers. 
In another study, some authors (Gaus & Hall, 2003) have been investigating the use of 
peptides for the development of new LDL biosensor.  Gaus & Hall (2003) selected short 
peptides sequences that showed binding selectivity towards native and oxidized LDL. 
Peptides were investigated for application in atherosclerosis risk monitoring using SPR 
technique. The peptides were immobilized on a gold SPR surface and LDL binding detected 
as a shift in the resonance. 3.7  107 (5.6  106) LDL/mm2/g/ml solution LDL were bound 
on GlySerAspGlu-OH and 6.8  107 (9.2  106) LDL/mm2/g/ml on GlyCystineSerAspGlu, 
compared with ~108 LDL/mm2/g/ml on LDL receptor ligand repeat peptide. They found 
a good correlation between LDL binding on these ligands and residual amino groups on the 
apoprotein of the LDL, which is an indicator of oxidation level. A very small sample (20 μl) 
could be taken for analysis and diluted 1:20 with physiological buffer prior to assay (giving 
total volume 0.4 ml). In addition to the obvious advantage in the required sample size, this 
has the effect of diluting potential plasma protein interference to levels where they no longer 
gave a significant background SPR response. 
According to Laffont et al. (2002) glycation is responsible for disruption of lipoprotein 
functions leading to the development of atherosclerosis in diabetes. Glycation is the result of 
the irreversible attachment of sugar moieties to NH2-protein groups, and is believed to play 
an important role in cardiovascular disease development among diabetic population 
through an impairment of lipoprotein functions. Glycation of lipoproteins as VLDL and 
HDL also affects their functional activities. Glycated VLDL display a higher residence time 
in plasma, are poorer substrates for lipoprotein lipase than non-glycated VLDL (Mamo et 
al., 1990), and glycation impairs paraoxonase activity in HDL (Hedrick et al., 2000). Laffont 
et al. (2002) also studied the effect of the early-glycation of apoE2, apoE3 and apoE4 on their 
binding to receptors. Glycated apoE binding to heparin and heparan sulfates (HS) was 
assessed by SPR technology (Laffont et al., 2002). Site-directed mutagenesis was then 
performed on Lys-75, the major glycation site of the protein. The prepared mutant protein 
proved to be useful as a tool to study the role of Lys-75 in apoE glycation. The results 
showed that, although glycation has no effect on apoE binding either to the LDL receptor 
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(LDL-R) or to scavenger receptor A (SR-A), it impairs its binding to immobilized heparin 
and HS. The glycation of Lys-75 was found to proceed rapidly and contributed significantly 
to total protein glycation. Laffont et al. (2002) showed that the glycation of Lys-75, a major 
glycation site in apoE, is a rapid process which contributes significantly to total apoE 
glycation. Although the glycation of apoE has no effect on its binding either to LDL-R or to 
SR-A, it impairs all three common apoE isoforms that bind to HS. 
Some authors (Kudo et al., 2001) have previously shown that Asp-hemolysin binds to 
oxidized LDL (OxLDL) in a concentration-dependent manner. They investigated the 
relationship between the oxidation extent of LDL and its binding activity to Asp-hemolysin, 
to assess the binding specificity of Asp-hemolysin for OxLDL with several scavenger 
receptor ligands and to attempt the real-time kinetic measurement of the Asp-hemolysin-
OxLDL interactions and calculations of the kinetic constants from SPR results. They showed 
that Asp-hemolysin has high affinity binding protein for OxLDL, and its binding specificity 
is distinct from any receptor for OxLDL. SPR studies revealed that OxLDL binds with high 
affinity (KD = 0.63 g/ml) to Asp-hemolysin. These studies suggest that Asp-hemolysin may 
bind to OxLDL using a mechanism different from the scavenger receptors. 
The self-assembly of molecular building blocks into ordered nanostructures is not only a key 
to various biological phenomena, but also an attractive route for fabricating novel 
biosystems. Choi et al. (2004) developed an antibody-based immunoassay system to detect 
LDL. The self-assembled monolayer of 11-mercaptoundecanoic acid (11-(MUA)) and 
hexanethiol mixture was fabricated to form the stable protein G layer. 3-
[(cholamidopropyl)dimethyl-ammonio]-1-propane sulfonate (CHAPS) was used for the 
regulation of protein G aggregate immobilized on the 11-(MUA) surface. The generic 
property of CHAPS made it possible to regulate the amount of protein immobilized on the 
surface. The anti-LDL layer on self-assembled protein G using CHAPS was applied to SPR 
immunosensor for detection of LDL and its detection limit was 100 pM. The relation with 
the change of SPR minimum angle and surface structure of fabricated layers with respect to 
the introduction of CHAPS implicate the importance of molecular control for the 
enhancement of immunosensor performance. 
Although, some authors (Snellings et al., 2003) have fabricated an acoustic wave biosensor 
for detection of lipoprotein fractions using dextran sulfate (DS) modified self-assembled 
monolayer of 11-mercapto-1-undecanol on gold (Au) surface, it has been found that DS 
coating is more selective to LDL fraction as compared to other lipoprotein fractions. 
However, the authors could not achieve reproducibility for coating DS onto a similar surface 
and the sensor lacked specificity. 
Lectin-like OxLDL receptor 1 (LOX-1) is the major OxLDL receptor of vascular endothelial 
cells and is involved in an early step of atherogenesis (Sawamura et al., 1997). LOX-1 is a 
membrane protein with a type II orientation consisting of four domains and the extracellular 
part of LOX-1 comprises an 82-residue stalk region (NECK) and a C-type lectin-like ligand-
binding domain (CTLD). The CTLD is connected to the NECK domain that has a coiled–coil 
sequence, which promotes LOX-1 homodimerization (Ishigaki et al., 2007). Ohki and 
collaborators (2010) revealed the functional significance of the clustered organization of the 
ligand-binding domain of LOX-1 with SPR. They have been used biotinylated CTLD 
immobilized on a streptavidin sensor chip to make CTLD clusters on the surface. Their 
results showed that a single homodimeric LOX-1 extracellular domain had lower affinity for 
OxLDL in the supramicromolar range of dissociation constant (KD). Single LOX-1 receptor 
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per se does not exert the full binding ability to OxLDL. Monomeric CTLD has shown rather 
marginal binding to OxLDL. A multivalent interaction between the clustered LOX-1 and 
OxLDL should be essential to gain biologically significant binding activity. The experiment 
with the W150A (W150 residue locates at the dimer interface) mutant suggested that each 
LOX-1 in the cluster must retain the proper CTLD dimer; otherwise, LOX-1 loses the 
binding activity to OxLDL. Regarding the reduced activity of W150A, Ohki et al. (2010) 
cannot rule out the possible contribution of the “hydrophobic tunnel” that runs through the 
dimer interface of the CTLD. This tunnel is proposed to be engaged in OxLDL recognition. 
Ohki et al. (2010), in combination with the analyses on the loss-of-binding mutant W150A, 
concluded that the clustered organization of the properly formed homodimeric CTLD is 
essential for the strong binding of LOX-1 to OxLDL. It was important to evaluate and 
understand the mode of LOX-1 binding to OxLDL to explain the initial step of 
atherogenesis. 
7. Electrochemical techniques 
An important point to electrochemical sensor design lies in the molecular understanding of 
the relationship between surface structure and reactivity. The fabrication of sensor materials 
with unique response characteristics has created a pressing need to understand their 
chemical and physical properties. Understanding the fundamental process that govern 
sensor response in most cases leads to the development of electroanalytical devices with 
superior selectivity, excellent chemical stability, higher sensitivity, and lower detection 
limits. In order to meet these needs, it has been necessary to study various electrical 
processes that occur at the surface of the sensor or inside the sensor matrix itself. 
Electrochemical biosensors constitute a rapidly growing area of interest to biotechnologists. 
These devices combine the analytical power of electrochemistry with the specificity of 
biological molecules for particular substrates.  
7.1 Cyclic voltammetry 
Voltammetry belongs to a category of electro-analytical methods, through the information 
about an analyte that is obtained by varying a potential and then measuring the resulting 
current (Brett & Brett, 1993). It is, therefore, an amperometric technique. Since there are 
many ways to vary a potential, there are also any forms of voltammetry, such as: 
polarography, linear sweep, differential staircase, normal pulse, reverse pulse and more 
(Brett & Brett, 1993; Bard & Faulkner, 2001). 
Cyclic voltammetry (CV) measurements are the current signals based on the electrochemical 
species consumed and/or generated during a biological and chemical interaction process of 
a biologically active substance and substrate (Oliveira et al., 2009; Oliveira et al., 2011). CV is 
one of the most widely used forms and it is useful to obtain information about the redox 
potential and electrochemical reaction (e.g. the chemical rate constant) of analyte solutions 
(Brett & Brett, 1993). In this case, this voltage is swept between two values at a fixed rate, 
however, when the voltage reaches V2 the scan is reversed and the voltage is swept back to 
V1, as is illustrated in Fig. 4a. The scan rate, (V2-V1)/(T2-T1), is a critical factor, since the 
duration of a scan must provide sufficient time to allow for a meaningful chemical reaction 
to occur. Varying the scan rate, therefore, yields correspondingly varied results (Bard & 
Faulkner, 2001). 
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Fig. 4. Cyclic voltammetry waveform (a) and typical cyclic voltammogram (b). Epc (Epa) and 
ipc (ipa) are the potential and current at cathodic (anodic) peak, respectively. 
The voltage is measured between the reference electrode and the working electrode, while 
the current is measured between working electrode and the counter electrode. The obtained 
measurements are plotted as current vs. voltage, also known as a voltammogram. As the 
voltage is increased toward the electrochemical reduction potential, the current will also 
increase. With increasing voltage toward V2 past this reduction potential, the current 
decreases, having formed a peak as the analyte concentration near the electrode surface 
diminishes, since the oxidation potential have been exceeded (Brett & Brett, 1993). As the 
voltage is reversed to complete the scan toward V1, the reaction will begin to reoxidize the 
product from the initial reaction. This produces an increase in current of opposite polarity as 
compared to forward scan, but again decreases, having formed a second peak as the voltage 
scan also provides information about the reversibility of a reaction at a given scan rate (Bard 
& Faulkner, 2001). There are two components to the current: (a) a capacitive component 
resulting from re-distribution of charged and polar species at the electrode surface (non-
Faradaic process) and (b) a component resulting from exchange of electrons between the 
electrode and redox species immobilized at the electrode surface, or free in solution 
(Faradaic process) (Bard & Faulkner, 2001). At sufficiently oxidizing or reducing potentials, 
where the ratio of electron transfer between the electrode and the redox species in solution 
is sufficiently fast, the Faradaic current is controlled by the rate of diffusion to the electrode. 
Hence, for the reversible reduction of redox species O:  
 O ne R   (8) 
With a redox potential E0, the Faradaic current, if, will depend on the concentration gradient 
of O at the electrode surface: 
 0
[ ]
( ) 0f
d O
i nFAD x
dx
   (9) 
where, A is the area of the electrode, D0 is the diffusion coefficient of O, n is the number of 
electrons transferred and F is Faraday’s constant. By holding the working electrode at a 
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positive potential and then sweeping towards and beyond E0, the surface concentration of O 
will change in accordance with the Nernst equation: 
 0
[ ]
exp[ ( )]
[ ]
O nF
E E
R RT
   (10) 
where, E is the electrode potential, R is the gas constant and T is the temperature in Kelvins.  
The shape of the voltammogram for a given compound depends not only on the scan rate 
and the electrode surface, which is different after each adsorption step, but also depends on 
the catalyst concentration. For example, increasing the concentration of reaction specific 
enzymes at a given scan rate will result in a higher current compared to the non-catalyzed 
reaction (Tan et al., 2005). 
The waveform of the voltage applied to a working electrode in CV is triangular shaped (i.e., 
the forward and reverse scan). Since, this voltage varies linearly with the time the scan rate 
is the slope (V/s). An example, of a CV for the reduction of ferricyanide to ferrocyanide 
(K4[Fe(CN)6]4-/K3[Fe(CN)6]3-) is shown in Fig. 4b. The peak shape of the reductive and 
reverse oxidative current vs. electrode potential curve (i-E) in Fig. 4b is typical of an 
electrode reaction in which the rate is governed by diffusion of the electroactive species to a 
planar electrode surface. That is the rate of the electron transfer step is fast compared to the 
rate at which ferricyanide is transported (diffuses) from the bulk solution to the electrode 
surface due to a concentration gradient, as ferricyanide is reduced to ferrocyanide. In such a 
case peak current, ip, is governed by the Randle-Sevcik relationship: 
 3/2 1/2 1/2bpi Kn AD c   (11) 
where the constant K = 2.72  105, n is the number of moles of electrons transferred per mole 
of electroactive species (e.g., ferricyanide), A is the area of the electrode in cm2, D is the 
diffusion coefficient in cm2/s, cb is the solution concentration in mole/l, and  is the scan 
rate of the potential in V/s. 
The ip is linearly proportional to the bulk concentration, cb, of the electroactive species, and 
the square root of the scan rate, 1/2. Thus, an important diagnostic is a plot of the ip vs. 1/2. 
If the plot is linear, it is reasonably safe to say that the electrode reaction is controlled by 
diffusion, which is the mass transport rate of the electroactive species to the surface of the 
electrode across a concentration gradient. The thickness () of the diffusion layer can be 
approximated by ~[Dt]1/2, where D is the diffusion coefficient and t is time in seconds. A 
quiet (i.e., unstirred solutions) is required. The presence of supporting electrolyte, such as 
KNO3 in this example, is required to prevent charged electroactive species from migrating in 
the electric field gradient (Bard & Faulkner, 2001). 
7.2 Electrochemical impedance spectroscopy 
Electrochemical impedance spectroscopy (EIS) has long been established as a sensitive 
technique to monitor the electrical response of a solid/liquid system subjected to the 
application of a periodic small amplitude AC signal. Analysis of the system response 
provides information concerning the solid/liquid interface and on the eventual occurrence 
of reactions at this local region (MacDonald, 1987). EIS is a non-destructive steady-state 
technique that is capable of probing the relaxation phenomena over a range of frequencies 
(Bockris et al., 2000; Bard & Faulkner, 2001; Macdonald, 1987). 
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The power of EIS lies in its ability to provide in situ information on relaxation times over the 
frequency range 106 to 10-4 Hz. It is a tool that has been used to identify and separate 
different contributions to the electric and dielectric responses of the biosystems. 
Impedance spectroscopy is a powerful method of analysing the complex electrical resistance 
of a system and is sensitive to surface phenomena and changes of bulk properties. The 
impedance Z of a system is generally determined by applying a voltage perturbation with 
small amplitude and detecting the current response. From this definition, the impedance Z 
is the quotient of the voltage-time function V(t) and the resulting current-time function I(t): 
 0
0
sin(2 )( ) 1
( ) sin(2 )
V ftV t
Z
I t I ft Y

     (12) 
where V0 and I0 are the maximum voltage and current signals, f is the frequency, t the time, 
 the phase shift between the voltage-time and current-time function, and Y is the complex 
conductance or admittance. The impedance is a complex value, since the current can differ 
not only in terms of the amplitude but it can also show a phase shift  compared to the 
voltage-time function. Thus, the value can be described either by the modulus Z and the 
phase shift  or alternatively by the real part Zr and the imaginary part Zi of the impedance. 
This is illustrated in Fig 5.    
 
 
Fig. 5. Impedance is a complex value that is defined as the quotient of the voltage (time) and 
current (time) functions. It can be expressed as the modulus Z and the phase angle , or it 
can be specified by the real (Zr) and the imaginary (Zi) parts of the impedance. 
Therefore, the results of an impedance measurement can be illustrated in two different 
ways: using a Bode plot which plots log Z and  as a function of log f, or a Nyquist plot 
which plots Zr and Zi. On the Nyquist plot the impedance (Fig. 6a) can be represented as a 
vector (arrow) of length Z . The angle between this vector and x-axis, commonly called the 
phase angle, is  (=argZ). 
Nyquist plots have one mayor shortcoming. When you look any data point on the plot, you 
cannot tell what frequency was used to record that point. This plot results from electrical 
circuit of Fig. 6b. Another popular representation method is the Bode plot. The impedance is 
plotted with log frequency on the x-axis and both the absolute values of the impedance  
(Z = Z0) and the phase-shift on the x-axis. 
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Fig. 6. Nyquist plot with impedance vector (a) and simple equivalent circuit with one time 
constant (b). 
In the typical biosensor application of EIS, the biological component is immobilized on the 
working electrode and the interaction with an analyte molecule is detected. The impedance 
of the sensing electrode (the working electrode modified with the biological component) 
controls the overall impedance. Like all electrochemical biosensors, impedimetric sensors 
are bioelectronic devices that make use of the interactions of biomolecules with a conductive 
(or semiconducting) transducer surface. The detection process involves the formation of the 
recognition complex between the sensing biomolecule and the analyte at the interface 
electronic transducer, which directly or indirectly alters the electrical properties of the 
recognition surface. 
7.3 Electrochemical LDL biosensors 
Cyclic voltammetry can be used to monitor the molecular interaction and explore 
association between biomolecules and LDL based on the modification at anodic and 
cathodic peaks. Nicolini’s group (Stura et al., 2007) improve the mechanical stability of 
electrodes based on P450scc for LDL-cholesterol detection and measure, using anodic 
porous alumina (APA). They have been shown, by means of CV measurements, that the 
sensitivity of the APA+P450scc system was slightly reduced with respect to the pure 
P450scc system, the readout was stable for a much longer period of time, and the measures 
remained reproducible inside a proper confidentiality band. To optimize the adhesion of 
P450scc to APA, a layer of poly-l-lysine, a poly-cation, was successfully implemented as 
intermediate organic structure. They obtained an optimization of the electron transfer's 
stability leading to the optimal detection of cholesterol in the clinical range concentration for 
longer times of use. 
In another work, Nicolini’s group (Antonini et al., 2004) employed Cytochrome 
P450sccK201E, mutated form of cytochrome P450scc native recombinant (P450sccNR), to 
study the enzyme–substrate interaction. The biochemical analysis was realized to observe 
the electrochemical responses of the engineerized enzyme to three different forms of 
cholesterol: free, LDL and high-density lipoproteins (HDL). The detection of the cholesterol 
was performed by electrochemical method using CV and chronoamperometry 
measurements. Compared to cytochrome P450sccNR, the cytochrome P450sccK201E 
displays a different behavior in the interaction with the substrate detection. The 
experimental data have shown that the mutation has improved the affinity between the 
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cytochrome P450 and the substrates; in particular, the best responses were found in the 
detection of cholesterol in HDL. CV and chronoamperometry results showed that 
electrochemical response of the mutant P450sccK201E and P450sccNR can be utilized for the 
cholesterol detection. 
Electrochemical methods associated with nanomaterials have been employed to develop 
electrochemical biosensor for the detection of LDL. More recently, a novel, sensitive, label-
free, LDL electrochemical biosensor was fabricated by adsorption of antibody to apoB-100. 
Yan et al. (2008) developed silver chloride/polyaniline (PANI) core-shell nanocomposites 
(AgCl/PANI) combined with gold nanoparticles (AuNPs) to prepare the AuNPs-
AgCl/PANI hybrid material. Yan et al. (2008) have been used a highly specific antibody, 
anti-apoB, that acts as a LDL receptor and fabricated an electrochemical biosensor by 
adsorption of anti-apoB on AuNPs-AgCl-polyaniline-modified glassy carbon electrode. The 
hybrid material could provide surface for high antibody loading due to its large surface-to-
volume ratio. Since each LDL has an apoB-100 on its phospholipids coat, they could be 
bonded to the electrode surface through the specific antibody-antigen reaction. EIS was used 
to characterize the recognition of LDL. The negative charges carried by LDL phospholipids 
coat would block the electron transfer of the K4[Fe(CN)6]4-/K3[Fe(CN)6]3- redox couple 
severely. In addition, the conductivity of LDL is very poor, so small amounts of LDL on the 
electrode could result in great change in the electron-transfer resistance. The biosensor 
exhibited a highly sensitive response to LDL with a detection limit of 0.34 pg/ml. 
In others studies, Langmuir-Blodgett (LB) films of polyaniline (PANI) were utilized for the 
fabrication of impedimetric immunosensor for detection of human plasma LDL by 
immobilizing anti-apoB via EDC-NHS coupling. Anti-apoB/PANI–stearic acid LB films 
immunoelectrodes studied by EIS spectroscopy revealed detection of LDL in the wide range 
of 0.018 μM (6 mg/dl) to 0.39 μM (130 mg/dl), covering the physiological range in blood, 
with a sensitivity of 11.25 kΩ μM−1 (Matharu et al., 2010). Therefore, from the different types 
of biosensors discussed above we showed that the possibility to detect LDL and modified 
LDL by piezoelectric, optical or electrical techniques such as QCM, SPR, VC and EIS are 
strategic in clinical diagnostics. 
8. Conclusion and future trend 
Studies based on LDL biosensors have been directed to decrease the detection time and 
develop new ways of detecting LDL and modified LDL. The techniques discussed here can 
provide information on the steady state or dynamics of real time events. Therefore, the 
combined application of QCM, SPR, VC and EIS is a powerful tool to the development of 
new biosensors for LDL and modified LDL. The trend in the clinical laboratory is the 
development of biosensors for multiplex detection targets. A biosensor that simultaneously 
measures multiple analytes (e.g., HDL, LDL, VLDL, modified LDL, total cholesterol, 
triglycerides, C-reactive protein and others) in a single assay and gives information about 
the cardiovascular risk profile in few minutes is a great challenge and warrants more studies 
in this field.  
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